WO2001052823A3 - Compositions to effect the release profile in the transdermal administration of drugs - Google Patents

Compositions to effect the release profile in the transdermal administration of drugs Download PDF

Info

Publication number
WO2001052823A3
WO2001052823A3 PCT/US2001/001999 US0101999W WO0152823A3 WO 2001052823 A3 WO2001052823 A3 WO 2001052823A3 US 0101999 W US0101999 W US 0101999W WO 0152823 A3 WO0152823 A3 WO 0152823A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
drugs
effect
release profile
transdermal administration
Prior art date
Application number
PCT/US2001/001999
Other languages
French (fr)
Other versions
WO2001052823A2 (en
Inventor
David Kanios
Original Assignee
Noven Pharma
David Kanios
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma, David Kanios filed Critical Noven Pharma
Priority to AU31043/01A priority Critical patent/AU3104301A/en
Publication of WO2001052823A2 publication Critical patent/WO2001052823A2/en
Publication of WO2001052823A3 publication Critical patent/WO2001052823A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Abstract

Compositions and methods for the transdermal delivery of active agents up to a period of seven days or more at substantially a zero-order release rate comprising a pharmaceutically acceptable adhesive matrix and a polymeric plastic material that provides a release rate regulating effect on the active agents.
PCT/US2001/001999 2000-01-20 2001-01-19 Compositions to effect the release profile in the transdermal administration of drugs WO2001052823A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31043/01A AU3104301A (en) 2000-01-20 2001-01-19 Compositions and methods to effect the release profile in the transdermal administration of active agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17710300P 2000-01-20 2000-01-20
US60/177,103 2000-01-20

Publications (2)

Publication Number Publication Date
WO2001052823A2 WO2001052823A2 (en) 2001-07-26
WO2001052823A3 true WO2001052823A3 (en) 2002-05-02

Family

ID=22647203

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/001999 WO2001052823A2 (en) 2000-01-20 2001-01-19 Compositions to effect the release profile in the transdermal administration of drugs

Country Status (3)

Country Link
US (2) US20020004065A1 (en)
AU (1) AU3104301A (en)
WO (1) WO2001052823A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Families Citing this family (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8294975B2 (en) 1997-08-25 2012-10-23 Donnelly Corporation Automotive rearview mirror assembly
WO2000041538A2 (en) * 1999-01-14 2000-07-20 Noven Pharmaceuticals, Inc. Dermal compositions
AU3104301A (en) 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
WO2007053710A2 (en) * 2005-11-01 2007-05-10 Donnelly Corporation Interior rearview mirror with display
DE10025971B4 (en) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system in plaster form with reduced tendency for drug crystallization and its use
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US6756379B2 (en) * 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6939873B2 (en) * 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
EP1333811A4 (en) * 2000-10-16 2004-03-03 Neopharm Inc Liposomal formulation of mitoxantrone
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8728445B2 (en) 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
DE60239528D1 (en) 2001-05-01 2011-05-05 Corium International Redwood City TWO-PHASE, WATER-ABSORBING BIOADHESIVE COMPOSITION
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
JP4865958B2 (en) 2001-05-23 2012-02-01 株式会社トクホン Analgesic anti-inflammatory patch with local action
EP1406633B1 (en) * 2001-06-18 2011-10-05 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
BR0211067A (en) * 2001-07-09 2006-10-31 Zonagen Inc Methods and Materials for the Treatment of Testosterone Deficiency in Men
US7737185B2 (en) * 2001-07-09 2010-06-15 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene
US6805878B2 (en) * 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
AU2003298514A1 (en) * 2002-05-17 2004-05-04 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
EP1514246A4 (en) 2002-06-06 2008-04-16 Donnelly Corp Interior rearview mirror system with compass
JPWO2003105841A1 (en) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 Antifungal pharmaceutical composition
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
EP1543358A2 (en) 2002-09-20 2005-06-22 Donnelly Corporation Mirror reflective element assembly
WO2004041240A1 (en) * 2002-11-05 2004-05-21 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
CN101569626B (en) * 2002-12-11 2012-02-08 塔罗制药工业有限公司 method of treating movement disorders using barbituric acid derivatives
WO2004064841A1 (en) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation and methods for the treatment of thrombocythemia
US20040161395A1 (en) * 2003-02-14 2004-08-19 Patil Anjali Abhimanyu Cosmetic compositions containing composite siloxane polymers
ME00147B (en) 2003-02-21 2010-10-10 Schering Ag Uv stable transdermal therapeutic plaster
US20070031463A1 (en) * 2003-02-26 2007-02-08 Spiros Fotinos Methods and devices for releasing volatile substances
US20070224284A1 (en) 2004-03-12 2007-09-27 John Devane Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
DK1603544T3 (en) * 2003-03-14 2008-01-14 Agi Therapeutics Res Ltd Treatment of intestinal conditions with N-2,3,3-tetramethylbicyclo [2.2.1] heptan-2-amine
DE10315878B4 (en) * 2003-04-08 2009-06-04 Schwarz Pharma Ag Device for transdermal administration of fesoterodine and use
KR101015546B1 (en) 2003-08-26 2011-02-16 조선대학교산학협력단 Patch preparation for nail
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
ATE448828T1 (en) * 2003-10-27 2009-12-15 Univ Basel TRANSDERMAL DRUG DELIVERY SYSTEM
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
ATE493981T1 (en) * 2003-11-04 2011-01-15 Supernus Pharmaceuticals Inc ONCE DAILY DOSAGE FORMS OF TROSPIUM
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
DE10360592A1 (en) * 2003-12-19 2005-07-28 Beiersdorf Ag Plaster system for the administration of antihistamines
DE10361306A1 (en) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wound dressing and wound dressing with a vasoconstrictive ingredient, and manufacturing method therefor
AU2005210637B2 (en) 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
US20050271597A1 (en) * 2004-02-13 2005-12-08 Keith Alec D Prostate hypertrophy treatment composition and method
US20070190125A1 (en) 2004-03-03 2007-08-16 Constantine Georgiades Positioning feature for aiding use of film or strip product
US20050237440A1 (en) * 2004-03-16 2005-10-27 Vision-Ease Lens Method and device to enhance the readability of a liquid crystal display through polarized lenses
KR100873664B1 (en) * 2004-04-28 2008-12-11 코스모세키유 가부시키가이샤 Hair restorer
UA88464C2 (en) * 2004-04-29 2009-10-26 Колдуэлл Гейлер, Инк. Method of topical methadone administration providing systemic effect
EP1611882B1 (en) * 2004-06-01 2010-04-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
WO2006003651A2 (en) * 2004-07-02 2006-01-12 Taro Pharmaceutical Industries, Ltd A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
US20080242726A1 (en) * 2004-07-14 2008-10-02 Podolski Joseph S Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
KR20070048229A (en) 2004-08-05 2007-05-08 코리움 인터네셔널, 인크. Adhesive composition
JP4745747B2 (en) * 2004-08-12 2011-08-10 日東電工株式会社 Fentanyl-containing patch preparation
JP4824963B2 (en) * 2004-08-12 2011-11-30 日東電工株式会社 Patch and patch preparation
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US20060121102A1 (en) * 2004-09-27 2006-06-08 Chia-Ming Chiang Transdermal systems for the delivery of estrogens and progestins
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
NZ582975A (en) 2004-10-21 2011-07-29 Durect Corp Transdermal delivery systems delivering sufentanil
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
JP4704764B2 (en) * 2005-02-03 2011-06-22 日東電工株式会社 Nail adhesive composition and nail patch
CN101115477A (en) * 2005-02-04 2008-01-30 雷普罗斯治疗公司 Methods and materials with trans-clomiphene for the treatment of male infertility
AU2006227243B2 (en) * 2005-03-22 2011-10-27 Allergan pharmaceuticals International Ltd. Dosing regimes for trans-clomiphene
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
AP2244A (en) * 2005-04-26 2011-06-24 Caldwell Galer Inc Topical methadone compositions and methods for using the same.
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
JP4800778B2 (en) * 2005-05-16 2011-10-26 日東電工株式会社 Dicing pressure-sensitive adhesive sheet and processing method of workpiece using the same
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
CA2609351C (en) 2005-05-24 2015-01-06 Chrono Therapeutics Inc. Portable drug delivery device
KR100764679B1 (en) * 2005-07-22 2007-10-09 익수제약 주식회사 Patches comprising paroxetine for transdermal application
AU2006299833B2 (en) 2005-10-12 2012-04-12 Besins Healthcare Luxembourg Sarl Improved testosterone gel and method of use
DE102005050654A1 (en) * 2005-10-20 2007-04-26 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH lip paving
DE102005050431A1 (en) 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the administration of lipophilic and / or less skin-permeable active ingredients
CA2646007A1 (en) * 2006-03-20 2007-09-27 Xytis Inc. Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
US20080039453A1 (en) * 2006-03-20 2008-02-14 David Putman Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use
US8569416B2 (en) 2006-06-06 2013-10-29 Dow Corning Corporation Single phase silicone acrylate formulation
KR101432698B1 (en) * 2006-06-06 2014-08-22 다우 코닝 코포레이션 A silicone acrylate hybrid composition
US8614278B2 (en) 2006-06-06 2013-12-24 Dow Corning Corporation Silicone acrylate hybrid composition and method of making same
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
ES2670407T3 (en) * 2006-09-03 2018-05-30 Techfields Biochem Co. Ltd Positively charged water-soluble acetaminophen prodrugs and compounds related to a very fast skin penetration rate
CN101511774B (en) * 2006-10-03 2015-05-13 于崇曦 Positively charged water-soluble prodrugs of mustard gas and related compounds with fast skin penetration rate
CN104987296B (en) * 2006-10-03 2018-11-23 于崇曦 Positively charged water-soluble prodrugs of mustards and related compounds with fast skin penetration rate
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
GB2443928A (en) * 2006-11-08 2008-05-21 Regen Therapeutics Plc Transdermal pharmaceutical composition comprising Zolpidem
EP2081576A4 (en) * 2006-11-14 2010-06-30 Taro Pharmaceuticals North Ame Method of improving bioavailability for non-sedating barbiturates
US8304420B2 (en) * 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
EP2098232B1 (en) * 2006-12-01 2013-06-05 Nitto Denko Corporation Percutaneous absorption preparation
BRPI0719307A2 (en) * 2006-12-01 2014-02-04 Nitto Denko Corp METHOD FOR THE DELETION OF DECOLORATION OVER TIME OF PREPARATION STICKING CONTAINING DONEPEZIL.
US20090099062A1 (en) * 2007-05-31 2009-04-16 Ethan Lee Pyrvinium For The Treatment of Cancer
JP2010529101A (en) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド NSAIA prodrug with very fast skin and membrane permeation rate and novel pharmaceutical use thereof
CN101147739B (en) * 2007-07-06 2010-12-08 北京康倍得医药技术开发有限公司 Composition containing rotigotine and its use and transdermal patch containing the composition
MX2010004195A (en) 2007-10-16 2010-06-02 Repros Therapeutics Inc Trans-clomiphene for metabolic syndrome.
JP5209433B2 (en) * 2007-10-19 2013-06-12 日東電工株式会社 Patch preparation
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US9155725B2 (en) * 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US20110028880A1 (en) * 2008-02-27 2011-02-03 Hisamitsu Pharmaceutical Co., Inc. Patch
US9700552B2 (en) * 2008-02-28 2017-07-11 Syntropharma Limited Pharmaceutical compositions for treatment of addiction
US20110056863A1 (en) * 2008-05-30 2011-03-10 Junichi Sekiya Adhesive preparation containing donepezil, and package of the same
CA2725484A1 (en) * 2008-05-30 2009-12-03 Eisai R&D Management Co., Ltd. Percutaneously absorbable preparation
EP2309993A1 (en) * 2008-06-25 2011-04-20 US Worldmeds LLC Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery
US8231906B2 (en) * 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
US8734944B2 (en) * 2008-07-28 2014-05-27 Dow Corning Corporation Composite article
ES2400210T3 (en) * 2008-10-02 2013-04-08 Mylan Inc. Method for preparing a multilayer adhesive laminate
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
DE102009008256A1 (en) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs of the type N-hydroxylated amidines, guanidines and / or aminohydrazones for application via the skin
CN102803420B (en) 2009-04-24 2015-06-03 汉高知识产权控股有限责任公司 Silicone acrylic hybrid polymer-based adhesives
US8741267B1 (en) 2009-06-26 2014-06-03 Joseph P. Trovato Method for treating periodontal disease
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
KR101831463B1 (en) 2010-03-26 2018-02-22 필립모리스 프로덕츠 에스.에이. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
EP2563347B1 (en) 2010-04-30 2016-10-12 Teikoku Pharma USA, Inc. Propynylaminoindan transdermal compositions
DE102010024105A1 (en) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermal administration of memantine
US10130684B2 (en) * 2011-02-03 2018-11-20 Pharmedica Ltd. Oral dissolving films for insulin administration, for treating diabetes
CN103476404B (en) 2011-03-24 2017-09-29 帝国制药美国公司 Transdermal composition comprising active agent layer and activating agent conversion coating
US8828426B2 (en) 2011-06-07 2014-09-09 Zx Pharma, Llc Multiparticulate L-carnitine compositions and related methods
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
UA113291C2 (en) 2011-08-04 2017-01-10 TRANSCLOMYPHENE METABOLITES AND THEIR APPLICATIONS
EP2584016A1 (en) 2011-10-21 2013-04-24 Dow Corning Corporation Single phase silicone acrylate formulation
CA2852957C (en) * 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
US20140243281A1 (en) * 2011-10-28 2014-08-28 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (en) 2011-11-23 2021-09-02 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
JP2013139554A (en) 2011-11-29 2013-07-18 Dow Corning Corp Silicone acrylate hybrid composition and method of making the same
US20130211351A1 (en) * 2012-01-31 2013-08-15 Gruenenthal Gmbh Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
RU2683934C2 (en) 2012-05-16 2019-04-03 Текфилдз Фарма Ко., Лтд. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
SG11201502681WA (en) 2012-11-02 2015-05-28 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
EP2914294A1 (en) 2012-11-02 2015-09-09 Repros Therapeutics Inc. Trans-clomiphene for use in cancer therapy
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
TW201431554A (en) * 2012-12-28 2014-08-16 Noven Pharma Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP2943479B1 (en) 2013-01-11 2020-04-15 Corsair Pharma, Inc. Prodrugs of treprostinil
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP6151935B2 (en) * 2013-03-11 2017-06-21 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US11717593B2 (en) * 2013-03-13 2023-08-08 Avery Dennison Corporation Improving adhesive properties
WO2015054608A1 (en) * 2013-10-11 2015-04-16 Xep, Inc. Energy patch
AR100562A1 (en) 2014-05-22 2016-10-12 Therapeuticsmd Inc PHARMACEUTICAL COMPOSITION OF ESTRADIOL AND PROGESTERONE FOR HORMONAL REPLACEMENT THERAPY
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
US10316228B2 (en) 2015-02-09 2019-06-11 Dow Silicones Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
EP3267982A4 (en) * 2015-03-13 2018-11-07 Amneal Pharmaceuticals LLC Fentanyl transdermal delivery system
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017136303A1 (en) 2016-02-05 2017-08-10 3M Innovative Properties Company Transdermal drug delivery systems with fluorosilicone release liners
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
WO2018115010A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
WO2018115001A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
ES2881783T3 (en) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic polymer
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11965120B2 (en) 2018-04-05 2024-04-23 3M Innovative Properties Company Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
MX2020014286A (en) 2018-06-20 2021-03-25 Lts Lohmann Therapie Systeme Ag Transdermal therapeutic system containing asenapine.
CA3112808A1 (en) 2018-09-27 2020-04-02 BioPhysics Pharma, Inc. Transdermal drug delivery system
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CA3232272A1 (en) * 2021-10-15 2023-04-20 Hans-Werner Wolf Transdermal therapeutic system for the transdermal administration of tizanidine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224981A2 (en) * 1985-11-04 1987-06-10 Paco Research Corporation Nitroglycerin transdermal delivery system
US4842864A (en) * 1987-03-25 1989-06-27 Laboratories D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient
DE4416927C1 (en) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Device for release of active agents from melt-type adhesive
US5662923A (en) * 1992-09-12 1997-09-02 Lts Lohmann Therapie-Systeme Gmbh & Co. Plaster for the transdermal application of steroid hormones, containing dexpanthenol
WO2000074661A2 (en) * 1999-06-05 2000-12-14 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542998B1 (en) 1983-03-24 1986-01-31 Rhone Poulenc Sante NEW TRANSDERMAL FORM OF ISOSORBIDE DINITRATE
US4584355A (en) 1984-10-29 1986-04-22 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4585836A (en) 1984-10-29 1986-04-29 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II
US4638043A (en) 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
USRE32991E (en) 1984-11-13 1989-07-18 Thermedics, Inc. Drug dispensing wound dressing
US4883669A (en) 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
JPH0744940B2 (en) 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application
US4839174A (en) 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US4840796A (en) 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
DE3908432A1 (en) 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts PLASTER AS A THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN WITH A LEVELED ACTIVE SUBSTANCE DELIVERY, METHOD FOR THE PRODUCTION AND USE THEREOF
US5118779A (en) 1989-10-10 1992-06-02 Polymedica Industries, Inc. Hydrophilic polyurethane elastomers
US5417671A (en) 1990-05-23 1995-05-23 Jackson; Richard R. Medical devices having local anesthetic effect and methods of their manufacture
US5232702A (en) 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
FR2699406B1 (en) 1992-12-21 1995-03-10 Commissariat Energie Atomique Films based on copolymers, their applications in transdermal systems and their preparation processes.
DE4336557C2 (en) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiol-containing transdermal therapeutic system, process for its preparation and its use
US5523095A (en) 1993-12-15 1996-06-04 Eastman Chemical Company Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
DE4405898A1 (en) 1994-02-18 1995-08-24 Schering Ag Transdermal therapeutic systems containing sex steroids
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (en) 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Plaster containing estradiol and its use
HUP9601442A3 (en) 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US5906814A (en) 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
US6461644B1 (en) 1996-03-25 2002-10-08 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
WO1998039042A1 (en) 1997-03-07 1998-09-11 Jackson Richard R Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
WO1998017263A1 (en) 1996-10-25 1998-04-30 Copley Pharmaceutical Inc. Transdermal patch
DE19700913C2 (en) 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of hormones
IT1294748B1 (en) 1997-09-17 1999-04-12 Permatec Tech Ag FORMULATION FOR A TRANSDERMAL DEVICE
CA2367100A1 (en) 1999-04-01 2000-10-12 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
AU3104301A (en) 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224981A2 (en) * 1985-11-04 1987-06-10 Paco Research Corporation Nitroglycerin transdermal delivery system
US4842864A (en) * 1987-03-25 1989-06-27 Laboratories D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient
US5662923A (en) * 1992-09-12 1997-09-02 Lts Lohmann Therapie-Systeme Gmbh & Co. Plaster for the transdermal application of steroid hormones, containing dexpanthenol
DE4416927C1 (en) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Device for release of active agents from melt-type adhesive
WO2000074661A2 (en) * 1999-06-05 2000-12-14 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Also Published As

Publication number Publication date
US20020004065A1 (en) 2002-01-10
AU3104301A (en) 2001-07-31
US6638528B1 (en) 2003-10-28
WO2001052823A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
WO2001052823A3 (en) Compositions to effect the release profile in the transdermal administration of drugs
WO1998014168A3 (en) Dosage form providing a sustained and ascending drug release
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
WO2002045701A3 (en) Crystallization inhibition of drugs in transdermal drug delivery systems
WO2001019337A3 (en) Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
WO2004105702A3 (en) Foamable pharmaceutical compositions and methods for treating a disorder
WO2005048996A3 (en) Modified release dosage forms of skeletal muscle relaxants
CA2494234A1 (en) Methods and dosage forms for controlled delivery of paliperidone
WO2006125819A3 (en) Oral microparticulate, anti-misuse drug formulation
ATE245450T1 (en) ADHESIVE MICROBEADS COMPREHENSIVE COMPOSITION FOR MEDICINAL ADMINISTRATION
AU6517496A (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
AU2001254711A1 (en) Sustained release vitamin composition
WO2001076575A3 (en) The treatment of respiratory diseases
NZ524767A (en) Composition for the transdermal delivery of fentanyl
AU2003221770A1 (en) Controlled release transdermal drug delivery
WO2009003125A8 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
WO2003028653A3 (en) Sustained release pharmaceutical compositions
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
SG159559A1 (en) Pharmaceutical product
WO2003009829A3 (en) Antiemetic, anti-motion sustained release drug delivery system
AU2223095A (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WA Withdrawal of international application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642